News from Bio-Conscious
Funding, product releases, research presentations and company announcements, in order. RSS feed · press contact contact@bioconscious.tech
Moms+ waitlist opens, California first
Bio-Conscious opens the public waitlist for Moms+, a pregnancy glucose program. Enrollment starts in California; the list is open to everyone.
Read Product ·Endobits Companion 5.0 is live on the App Store
A complete rebuild of the companion app for people who wear a CGM: Apple Health and DIY-rig sensor input, glucose forecasting, and a direct line to your clinic.
Read Funding ·The Government of Canada invests $1.5M in Bio-Conscious to bring Endobits to hospitals across Canada and the U.S.
As part of a $17.3M PacifiCan investment across eight B.C. technology companies, Bio-Conscious received $1.5 million to commercialize Endobits.
Read Press release ·Bio-Conscious integrates GPT-4 into Endobits V5
Endobits AI Assist drafts chart notes from CGM data and gives clinicians in-context access to American Diabetes Association guidance.
Read Press release ·Bio-Conscious launches Endobits V5, an automated remote patient management platform for diabetes care
Endobits V5 applies machine learning to CGM data so care teams find high-risk patients sooner and act before an admission.
Read Research ·Diabits presented at the 79th ADA Scientific Sessions
Poster 922-P: Diabits, an AI-powered smartphone application for glucose prediction, presented in San Francisco.
Read Research ·Predicting future glucose fluctuations, presented at the 78th ADA Scientific Sessions
Poster 738-P: machine-learning prediction of glucose fluctuations from CGM data, presented in Orlando.
ReadGet Bio-Conscious in your Google results. Add us as a preferred source and our latest research and guides surface first in Top Stories.